Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices

被引:80
|
作者
Worth, Leon J. [1 ,2 ]
Seymour, John F. [3 ]
Slavin, Monica A. [2 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic 3002, Australia
[2] Royal Melbourne Hosp, Ctr Clin Res Excellence Infect Dis, Victorian Infect Dis Serv, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Parkville, Vic 3050, Australia
关键词
CVC-related bloodstream infection; Thrombosis; Peripherally inserted CVC; Nontunneled CVC; Hematology; Surveillance; BLOOD-STREAM INFECTIONS; NOSOCOMIAL INFECTIONS; CELL TRANSPLANTATION; BONE-MARROW; LONG-TERM; SURVEILLANCE; PREVENTION; GUIDELINES; EFFICACY; RISK;
D O I
10.1007/s00520-008-0561-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Central venous catheter (CVC)-related bloodstream infection (CR-BSI) is a significant complication in hematology patients. A range of CVC devices may be used, and risks for the development of complications are not uniform. The objectives of this study were to determine the natural history and rate of CVC-related complications and risk factors for CR-BSI and to compare device-specific complications in a hematology population. An observational cohort of patients with hematologic malignancy was prospectively studied following CVC insertion. Participants were reviewed until a CVC-related complication necessitated device removal, completion of therapy, death, or defined end-of-study date. The National Nosocomial Infection Surveillance definition for CR-BSI was used. Overall and device-specific rates of infective and noninfective complications were calculated and potential risk factors were captured. One hundred six CVCs (75 peripherally inserted central venous catheters [PICCs], 31 nontunneled CVCs) were evaluated in 66 patients, over 2,399 CVC days. Thrombosis occurred in 16 cases (15.1%), exit-site infection in two (1.9%), and CR-BSI in 18 (7.5 per 1,000 CVC days). No significant differences were found when complication rates in PICC and nontunneled devices were compared. An underlying diagnosis of acute myeloid leukemia was negatively associated with CR-BSI (odds ratio (OR) 0.14, p = 0.046), and a previous diagnosis of fungal infection was associated with infection (OR 22.82, p = 0.031). CR-BSI rates in our hematology population are comparable to prior reports. A low rate of exit-site infection and high proportion of thrombotic complications were observed. No significant differences in thrombotic or infective complications were evident when PICC and nontunneled devices were compared. PICC devices are a practical and safe option for management of hematology patients.
引用
收藏
页码:811 / 818
页数:8
相关论文
共 50 条
  • [1] Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices
    Leon J. Worth
    John F. Seymour
    Monica A. Slavin
    Supportive Care in Cancer, 2009, 17
  • [2] Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies
    Boersma, R. S.
    Jie, K. -S. G.
    Verbon, A.
    van Pampus, E. C. M.
    Schouten, H. C.
    ANNALS OF ONCOLOGY, 2008, 19 (03) : 433 - 442
  • [3] Thrombotic complications of implanted central venous access devices: prospective evaluation
    Labourey, JL
    Lacroix, P
    Genet, D
    Gobeaux, F
    Martin, J
    Venat-Bouvet, L
    Lavau-Denes, S
    Maubon, A
    Tubiana-Mathieu, N
    BULLETIN DU CANCER, 2004, 91 (05) : 431 - 436
  • [4] Thrombotic complications of central venous catheters in cancer patients
    Kuter, DJ
    ONCOLOGIST, 2004, 9 (02): : 207 - 216
  • [5] Thrombotic complications of central venous catheters in cancer patients
    Monreal, M
    Davant, E
    ACTA HAEMATOLOGICA, 2001, 106 (1-2) : 69 - 72
  • [6] Thrombotic complications of central venous catheters in cancer patients
    Bona, RD
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (02): : 147 - 155
  • [7] THROMBOTIC COMPLICATIONS OF CENTRAL VENOUS CATHETERS
    HAIDVOGL, M
    MUTZ, I
    MESSNER, H
    WENDLER, H
    ZEITSCHRIFT FUR KINDERCHIRURGIE UND GRENZGEBIETE, 1974, 15 (01): : 1 - 9
  • [8] Comparison of complications between transjugular and axillosubclavian approach for placement of tunneled, central venous catheters in patients with hematological malignancy: a prospective study
    Lee, SH
    Hahn, ST
    EUROPEAN RADIOLOGY, 2005, 15 (06) : 1100 - 1104
  • [9] Comparison of complications between transjugular and axillosubclavian approach for placement of tunneled, central venous catheters in patients with hematological malignancy: a prospective study
    Sang Hoon Lee
    Seong Tai Hahn
    European Radiology, 2005, 15 : 1100 - 1104
  • [10] TEICOPLANIN AND ORAL CIPROFLOXACIN AS OUTPATIENT TREATMENT OF INFECTIVE EPISODES IN PATIENTS WITH INDWELLING CENTRAL VENOUS CATHETERS AND HEMATOLOGICAL MALIGNANCY
    KETLEY, NJ
    KELSEY, SM
    NEWLAND, AC
    CLINICAL AND LABORATORY HAEMATOLOGY, 1995, 17 (01): : 71 - 74